查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387372

花粉症市場報告：到 2030 年的趨勢、預測和競爭分析

Pollen Allergy Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

花粉症趨勢和預測

預計到 2030 年，全球花粉症市場將達到 72 億美元，2024 年至 2030 年年複合成長率為 4.5%。該市場的主要驅動力是過敏發生率的增加、過敏及其管理意識的提高以及持續的技術進步。由於食品、吸入劑和藥品市場的商機，全球花粉症市場的未來充滿希望。

花粉症市場洞察

Lucintel 表示，由於皮質類固醇的功效、安全性和可用性，在預測期內將繼續成為最大的市場。

在這個市場中，由於呼吸道過敏的高成長，吸入器仍將是最大的細分市場。

由於花粉症的高發生率和醫療基礎設施未得到滿足，預計亞太地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球花粉症市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球花粉症市場趨勢（2018-2023）與預測（2024-2030）
  • 按藥物類別分類的全球花粉症市場
    • 抗組織胺藥
    • 鼻減充血劑
    • 皮質類固醇
    • 肥大細胞穩定劑
    • 白三烯抑制劑
    • 鼻用抗膽鹼能藥物
    • 免疫調節劑
    • 自動注射腎上腺素
    • 免疫療法
  • 按產品類型分類的全球花粉症市場
    • 裝置
    • 消耗品
    • 服務
  • 按過敏原類型分類的全球花粉症市場
    • 食品
    • 吸入
    • 藥品
    • 其他
  • 按最終用途分類的全球花粉症市場
    • 診斷實驗室
    • 醫院
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的全球花粉症市場
  • 北美花粉症市場
  • 歐洲花粉症市場
  • 亞太花粉症市場
  • 其他地區花粉症市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按藥物類別分類的全球花粉症市場成長機會
    • 按產品類別分類的全球花粉症市場成長機會
    • 按過敏原類型分類的全球花粉症市場成長機會
    • 全球花粉症市場成長機會（依最終用途）
    • 全球花粉症市場成長機會（按地區）
  • 全球花粉症市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球花粉症市場的產能
    • 全球花粉症市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan
簡介目錄

Pollen Allergy Trends and Forecast

The future of the global pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets. The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are growing occurence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

A more than 150-page report is developed to help in your business decisions.

Pollen Allergy by Segment

The study includes a forecast for the global pollen allergy by therapeutics drug class, product type, allergen type, end use, and region.

Pollen Allergy Market by Therapeutics Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Auto Injectable Epinephrine
  • Immunotherapy

Pollen Allergy Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Pollen Allergy Market by Allergen Type [Shipment Analysis by Value from 2018 to 2030]:

  • Food
  • Inhaled
  • Drug
  • Others

Pollen Allergy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Laboratories
  • Hospitals
  • Others

Pollen Allergy Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pollen Allergy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pollen allergy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pollen allergy companies profiled in this report include-

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan

Pollen Allergy Market Insights

Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availabiliy.

Within this market, inhaled will remain the largest segment due to high growth of respiratory allergies.

APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Features of the Global Pollen Allergy Market

Market Size Estimates: Pollen allergy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pollen allergy market size by various segments, such as by therapeutics drug class, product type, allergen type, end use, and region in terms of value ($B).

Regional Analysis: Pollen allergy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutics drug classes, product types, allergen types, end uses, and regions for the pollen allergy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pollen allergy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the pollen allergy market size?

Answer: The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030.

Q2. What is the growth forecast for pollen allergy market?

Answer: The global pollen allergy market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pollen allergy market?

Answer: The major drivers for this market are growing occurence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

Q4. What are the major segments for pollen allergy market?

Answer: The future of the pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key pollen allergy market companies?

Answer: Some of the key pollen allergy companies are as follows:

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan

Q6. Which pollen allergy market segment will be the largest in future?

Answer: Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availabiliy.

Q7. In pollen allergy market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pollen allergy market by therapeutics drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy), product type (instruments, consumables, and services), allergen type (food, inhaled, drug, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pollen Allergy Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pollen Allergy Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pollen Allergy Market by Therapeutics Drug Class
    • 3.3.1: Antihistamines
    • 3.3.2: Decongestants
    • 3.3.3: Corticosteroids
    • 3.3.4: Mast Cell Stabilizers
    • 3.3.5: Leukotriene Inhibitors
    • 3.3.6: Nasal Anticholinergics
    • 3.3.7: Immunomodulators
    • 3.3.8: Auto injectable Epinephrine
    • 3.3.9: Immunotherapy
  • 3.4: Global Pollen Allergy Market by Product Type
    • 3.4.1: Instruments
    • 3.4.2: Consumables
    • 3.4.3: Services
  • 3.5: Global Pollen Allergy Market by Allergen Type
    • 3.5.1: Food
    • 3.5.2: Inhaled
    • 3.5.3: Drug
    • 3.5.4: Others
  • 3.6: Global Pollen Allergy Market by End Use
    • 3.6.1: Diagnostic Laboratories
    • 3.6.2: Hospitals
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pollen Allergy Market by Region
  • 4.2: North American Pollen Allergy Market
    • 4.2.2: North American Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.3: European Pollen Allergy Market
    • 4.3.1: European Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.3.2: European Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.4: APAC Pollen Allergy Market
    • 4.4.1: APAC Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.4.2: APAC Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.5: ROW Pollen Allergy Market
    • 4.5.1: ROW Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.5.2: ROW Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pollen Allergy Market by Therapeutics Drug Class
    • 6.1.2: Growth Opportunities for the Global Pollen Allergy Market by Product Type
    • 6.1.3: Growth Opportunities for the Global Pollen Allergy Market by Allergen Type
    • 6.1.4: Growth Opportunities for the Global Pollen Allergy Market by End Use
    • 6.1.5: Growth Opportunities for the Global Pollen Allergy Market by Region
  • 6.2: Emerging Trends in the Global Pollen Allergy Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pollen Allergy Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pollen Allergy Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: ALK-Abello
  • 7.2: Circassia
  • 7.3: DBV Technologies
  • 7.4: Genentech
  • 7.5: GlaxoSmithKline
  • 7.6: HAL Allergy
  • 7.7: Johnson & Johnson
  • 7.8: Meda AB
  • 7.9: Merck & Co
  • 7.10: Mylan